Pricing

Log inSign up

Atalanta Therapeutics

1 follower

‌

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing the proprietary RNA interference platform.

Industries

Biotechnology, Education

Headquarters

Boston, United States

Employees

11-50

Links

Org chart

Alicia Secor
President & CEO

Alicia Secor

Collapse
Aimee L. Jackson
Chief Scientific Officer
Morgan Molloy
Chief Corporate Development Officer
Bart G. Newland
General Counsel
Michele Keough
SVP, Program & Alliance Management
Stephen Burke
SVP, Human Resources
Brittany Ferdman
Purchasing Coordinator
Anastasia Khvorova
Co-founder
Craig Mello
Co-founder
Jeff Young
Chief Financial Officer
Serena Hung
Chief Medical Officer
Antonio N.
Sr. Director Information Technology
RJ
Rachael Johnson
Executive Assistant

Teams

+8

Scientific Research Team

11 members

+7

Scientific and Technical Advisory

10 members

+4

Leadership Team

7 members

+1

Operations Team

4 members

+2

Research and Development

5 members

Offices

Similar companies

BioAge

3 followers

MBX Biosciences

2 followers

Nuvalent

1 follower

Calico

6 followers

Qualigen Therapeutics

3 followers

Caribou Biosciences

2 followers

89bio

2 followers

Pyxis Oncology

2 followers

PepGen

2 followers

Entos

1 follower

Cargo

1 follower

Explore companies